Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.754 SEK | -1.90% | +3.42% | -1.02% |
Sales 2021 | 844K 77.31K | Sales 2022 | 1.14M 105K | Capitalization | 595M 54.52M |
---|---|---|---|---|---|
Net income 2021 | -156M -14.29M | Net income 2022 | -168M -15.39M | EV / Sales 2021 | 1,710 x |
Net cash position 2021 | 254M 23.28M | Net cash position 2022 | 68.47M 6.27M | EV / Sales 2022 | 460 x |
P/E ratio 2021 |
-10.9
x | P/E ratio 2022 |
-3.54
x | Employees | 11 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.34% |
Latest transcript on Immunovia AB
1 day | -1.90% | ||
1 week | +3.42% | ||
Current month | +28.22% | ||
1 month | +28.97% | ||
3 months | -9.68% | ||
6 months | +182.90% | ||
Current year | -1.02% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.754 | -1.90% | 233,227 |
24-04-18 | 1.788 | +1.94% | 109,354 |
24-04-17 | 1.754 | -6.20% | 158,116 |
24-04-16 | 1.87 | +3.31% | 175,130 |
24-04-15 | 1.81 | +6.72% | 648,398 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.02% | 7.28M | |
-46.92% | 2.62B | |
+7.27% | 1.7B | |
-15.17% | 1.41B | |
+18.55% | 1.16B | |
-15.69% | 968M | |
-24.43% | 865M | |
-9.20% | 699M | |
-17.12% | 690M | |
+5.90% | 491M |
- Stock Market
- Equities
- IMMNOV Stock